Athens Research & Technology, Inc.

John Mitchell, CEO of Athens Research and Technology, is a seasoned executive with over 25 years of leadership experience in C-suite roles, including product development, operations, and CEO positions. Throughout his career, he has led research teams and organizations in material science, medtech, and life sciences, developing over 150 products across these markets.

Athens Research and Technology (ART), founded by UGA, has a 38-year history of providing highly pure native proteins to academic researchers, as well as IVD and cell culture media manufacturers worldwide. ART was honored with the 2022 Georgia Globe Award for its international sales growth. Over the past 10 years, ART proteins have been featured in 1,500 different academic peer-reviewed journals.